A description of variant transthyretin amyloidosis (ATTRv) stage 1 patients and asymptomatic carriers in Spain: the EMPATIa study gan Lucía Galán Dávila, Fernando Martinez Valle, Juan Buades Reinés, Juan Gonzalez-Moreno, Inés Losada López, Teresa Sevilla, Francisco Muñoz Beamud, José Eulalio Bárcena Llona, Manuel Romero Acebal, Francesca Setaro, Diana Primiano, Patricia Tarilonte

Cael y testun llawn

Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv) gan Juan González-Moreno, Álvaro Gragera-Martínez, Adrián Rodríguez, Cristina Borrachero-Garro, Sandra García-Garrido, Carles Barceló, Ana Manovel-Sánchez, Maria Antonia Ribot-Sansó, Lesly Ibargüen-González, Rosa Gomila, Francisco Muñoz-Beamud, Inés Losada-López, Eugenia Cisneros-Barroso

Cael y testun llawn

Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission gan Mercedes García-Gasalla, Juana M. Ferrer, Pablo A. Fraile-Ribot, Adrián Ferre-Beltrán, Adrián Rodríguez, Natalia Martínez-Pomar, Luisa Ramon-Clar, Amanda Iglesias, Inés Losada-López, Francisco Fanjul, Joan Albert Pou, Isabel Llompart-Alabern, Nuria Toledo, Jaime Pons, Antonio Oliver, Melchor Riera, Javier Murillas

Cael y testun llawn